Michael Schmertzler sold 20,000 PTC Therapeutics shares across three transactions dated 2026-09-09 and 2026-09-10, at prices ranging from $67.34 to $68.67 per share. He owned 1,316,594 shares afterward. The post-sale holding shows the reported ownership position investors can assess.

Key Highlights

  • The PTC Therapeutics shares sold for between $67.34 and $68.67 per share.
  • The transactions occurred on 9 September 2026 and 10 September 2026, all using code S.
  • Michael Schmertzler owned 1,316,594 PTC Therapeutics shares after the transactions.

PTC Therapeutics, Inc. (NASDAQ: PTCT) saw Michael Schmertzler sell 20,000 shares in separate transactions. Michael Schmertzler was the seller named in the transaction record.

Three Transactions Cover $67.34 to $68.67 Per Share

Three separate transactions made up the reported activity. The prices ranged from $67.34 to $68.67 per share. The transactions were dated 9 September 2026 and 10 September 2026. Schmertzler owned 1,316,594 shares after the transactions.